Bone Disease Services
-
by Amgen Inc.based in USA
We have a presence in approximately 100 countries and regions worldwide and our innovative medicines have reached millions of people in the fight against serious illnesses. We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Our medicines typically address diseases for ...
-
based in UNITED KINGDOM
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers such as steroidal and hormonal substances in the low picogram range. We have also invested in the field of multiplexing, using ...
-
based in JAPAN
Focusing on the three key therapeutic areas: bone and joint, respiratory, and cardiovascular and metabolic diseases, the Teijin Group is promoting global business expansion led by the twin driving forces of pharmaceuticals and home ...
-
based in CANADA
ActLabs Biotech scientists can assist with innovative biomarker assay development and validation. To compliment our range of immunoassays, we also offer LC-MS/MS technology that has enabled us to extend our portfolio to include more biomarkers. In addition, we have invested in the field of multiplexing, using a bead-based suspension and electro-chemiluminescence-based platform ( Luminex Biorad ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you